ACADIA Pharmaceuticals Inc.

In News

Candriam S.C.A. Buys New Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat

MarketBeat - Feb 11, 2026

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Business Wire

Business Wire - Feb 04, 2026

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Reveals 34% Upside Potential Amid Robust CNS Pipeline - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 10, 2026

Is It Too Late To Consider ACADIA Pharmaceuticals (ACAD) After Its Recent Share Price Rebound? - Yahoo Finance

Yahoo Finance - Feb 02, 2026

Biotech Stocks Diverge As Genetic Disease Drug Fails - Investor's Business Daily

Investor's Business Daily - Sep 24, 2025

Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union - BioSpace

BioSpace - Feb 03, 2026

Can ACADIA Pharmaceuticals Inc. stock sustain institutional interest - CEO Change & Weekly High Potential Alerts - mfd.ru

mfd.ru - Feb 12, 2026

Acadia Pharmaceuticals’ CEO on rebranding, using AI as a small biotech - Medical Marketing and Media

Medical Marketing and Media - Oct 20, 2025

Rett and Alzheimer’s drug maker Acadia projects $1.7B sales by 2028 - Stock Titan

Stock Titan - Jan 13, 2026

Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno - Fierce Pharma

Fierce Pharma - Sep 24, 2025

Insider Selling: ACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Sells 6,950 Shares of Stock - MarketBeat

MarketBeat - Feb 11, 2026

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Yahoo Finance - Aug 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment